Drug Profile

WQ 2942

Alternative Names: WQ 3345

Latest Information Update: 17 Oct 2007

Price :

$50 ^*

Note:

Adis is an information provider. We do not sell or distribute actual drugs.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

Originator Wakunaga Pharmaceutical
Class Antibacterials; Ethanolamines; Quinolones
Mechanism of Action DNA topoisomerase inhibitors

Orphan Drug Status

Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

No

Highest Development Phases

Discontinued Bacterial infections

Most Recent Events

17 Oct 2007 Discontinued - Preclinical for Bacterial infections in Japan (unspecified route)
30 Apr 2001 WQ 2942 is available for licensing worldwide (http://www.wakunaga.co.jp)
15 Nov 1999 Preclinical development for Bacterial infections in Japan (Unknown route)

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com